The landscape of hypertension management is evolving, and the 2025 guidelines offer significant updates since their 2017 predecessors. Our new video provides a concise overview of these changes, covering critical areas from detection and evaluation to new treatment strategies. We delve into updated measurement recommendations, the emphasis on primary aldosteronism screening, and revised treatment targets. This informative resource is designed to help you understand the latest insights and implications for patient care.
Guests: Dr. McGinn, Dr. Sagar, and Dr. Kavita Chawla, Director of EBM Education, Virginia Mason Franciscan Health
Guidelines: https://www.ahajournals.org/doi/10.1161/HYP.0000000000000249
